NCT00426998View on ClinicalTrials.gov

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2006

Conditions
Choroidal NeovascularizationMacular Degeneration
Interventions
DRUG

Verteporfin

DRUG

Bevacizumab

Trial Locations (1)

95819

Retinal Consultants Medical Group, Inc., Sacramento

All Listed Sponsors
lead

Retinal Consultants Medical Group

OTHER

NCT00426998 - Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD | Biotech Hunter | Biotech Hunter